The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Xi encourages customs workers to better serve nation
Trump sets fundraising record with $50.5M from Florida event
Overseas experts hail Xi's notion of building modern Chinese civilization
French sports minister calls for sanctions after Monaco player tapes over anti
State Council stresses work on flood relief, rebuilding
Russia says Moscow terror attack suspects planned to flee to Kiev for reward
Mainland's Taiwan affairs official meets KMT vice chairman
Salvador Perez homers, Bobby Witt Jr. scores 4 times as Royals beat Mets 11